БОЛЕВАЯ ФОРМА ДИАБЕТИЧЕСКОЙ ПЕРИФЕРИЧЕСКОЙ НЕЙРОПАТИИ



Литература


1. Галстян Г.Р., Старостина Е.Г., Яхно Н.Н. с соавт. Диагностика и рациональная терапия болевой формы диабетической периферической нейропатии: междисциплинарныйконсенсус экспертов. Сахарный диабет. 2019; 4: 305–327.


2. Daousi C., MacFarlane I.A., Woodward A. et al. Chronic painful peripheral neuropathy in anurban community: a controlled comparison of people with and without diabetes. Diabet Med.2004; 21(9): 976–82. doi: 10.1111/j.1464-5491.2004.01271.x


3. Davies M., Brophy S., Williams R., Taylor A. The prevalence, severity, and impact of painfuldiabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29(7): 1518–22. doi:10.2337/dc05-2228.


4. Ziegler D., Rathmann W., Dickhaus T. et al. Neuropathic pain in diabetes, prediabetes andnormal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009;10(2):393–400. doi: 10.1111/j.1526-4637.2008.00555.x.


5. Malik R.A., Veves A., Tesfaye S. et al. Small fibre neuropathy: role in the diagnosis of diabeticsensorimotor polyneuropathy. Diabetes Metab Res Rev. 2011; 27(7): 678–84. doi: 10.1002/dmrr.1222.


6. Baron R., Tolle T.R., Gockel U. et al. A cross-sectional cohort survey in 2100 patients withpainful diabetic neuropathy and postherpetic neuralgia: differences in demographic data andsensory symptoms. Pain. 2009; 146(1–2): 34–40. doi: 10.1016/j.pain.2009.06.001


7. Freeman R., Baron R., Bouhassira D. et al. Sensory profiles of patients with neuropathic painbased on the neuropathic pain symptoms and signs. Pain. 2014; 155(2): 367–76. doi: 10.1016/j.pain.2013.10.023.


8. Boulton A.J.M., Malik R.A., Arezzo J.C., Sosenko J.M. Diabetic somatic neuropathies. DiabetesCare. 2004; 27(6): 1458–86. doi: 10.2337/diacare.27.6.1458.


9. Tesfaye S., Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheralneuropathy? Curr Diab Rep. 2009; 9(6): 432–34. doi: 10.1007/s11892-009-0070-1.


10. Boulton A.J., Armstrong D.G., Albert S.F. et al. Comprehensive foot examination and riskassessment: a report of the task force of the foot care interest group of the American DiabetesAssociation, with endorsement by the American Association of Clinical Endocrinologists.Diabetes Care. 2008; 31(8): 1679–85. doi: 10.2337/dc08-9021.


11. Finnerup N.B., Attal N., Haroutounian S. et al. Pharmacotherapy for neuropathic pain in adults:systematic review, meta-analysis and updated NeuPSIG recommendations. Lancet Neurol.2015; 14(2): 162–73. doi: 10.1016/S1474-4422(14)70251-0.


12. http://grls.rosminzdrav.ru (date of access – 01.10.2020).


13. Moore R.A., Derry S., Aldington D. et al. Amitriptyline for neuropathic pain in adults. CochraneDatabase Syst Rev. 2015; 2015(7): CD008242. doi: 10.1002/14651858.CD008242.pub3.


Бионика Медиа